FDA.reportPublic FDA data

cabergoline 0.5 MG Oral Tablet

RxCUI
199703
RxNorm name
cabergoline 0.5 MG Oral Tablet
Display name
cabergoline 0.5 MG Oral Tablet
Full name
cabergoline 0.5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CabergolineCABERGOLINEMylan Pharmaceuticals Inc.e497366b-a124-4d7f-bd45-a883c392d4bb2026-06-30Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutionsc9f0b576-d5e5-4e3e-bb5c-3574d75d99072026-03-19Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINESOLA Pharmaceuticals, LLC275a6a25-c3c9-4258-a610-0b00752517f72025-12-08Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions9405c116-4a77-4e14-9ab8-25e899595cdf2025-08-27Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEIngenus Pharmaceuticals, LLC57cbd81e-fdb9-4060-80ee-6e8581c463a42025-07-04Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINETeva Pharmaceuticals USA, Inc.74b61e8a-7ae9-4996-85ec-df23c56de16f2025-06-16Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEStrides Pharma Science Limited518d43ee-8d33-4abd-96a5-1b6890e59b082025-04-01Warnings, Adverse reactionsExact identifier
rxcui: 199703
CABERGOLINECABERGOLINESomerset Therapeutics, LLCe0fb5556-de2c-4822-9960-0700e29078902024-11-14Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEAmneal Pharmaceuticals NY LLCa246b015-e19c-4b4f-9089-aea1108687ba2024-10-03Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions7699d938-3f62-4e13-9b33-3e581310b9f32023-08-28Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.bc44d11b-b3f0-4e3d-9da3-4f8852d117342023-07-27Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions89ec147b-a6fe-49bb-9af5-52fc2ce5db7f2023-04-12Warnings, Adverse reactionsExact identifier
rxcui: 199703

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
74b61e8a-7ae9-4996-85ec-df23c56de16fcabergoline 0.5 MG Oral TabletPSN21These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250616
74b61e8a-7ae9-4996-85ec-df23c56de16fcabergoline 0.5 MG Oral TabletSCD21These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250616
57cbd81e-fdb9-4060-80ee-6e8581c463a4cabergoline 0.5 MG Oral TabletSCD12These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250704
57cbd81e-fdb9-4060-80ee-6e8581c463a4cabergoline 0.5 MG Oral TabletPSN12These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250704
e497366b-a124-4d7f-bd45-a883c392d4bbcabergoline 0.5 MG Oral TabletPSN11These highlights do not include all the information needed to use CABERGOLINE safely and effectively. See full prescribing information for CABERGOLINE. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250930
e497366b-a124-4d7f-bd45-a883c392d4bbcabergoline 0.5 MG Oral TabletSCD11These highlights do not include all the information needed to use CABERGOLINE safely and effectively. See full prescribing information for CABERGOLINE. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250930
c9f0b576-d5e5-4e3e-bb5c-3574d75d9907cabergoline 0.5 MG Oral TabletSCD10These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620260319
c9f0b576-d5e5-4e3e-bb5c-3574d75d9907cabergoline 0.5 MG Oral TabletPSN10These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620260319
89ec147b-a6fe-49bb-9af5-52fc2ce5db7fcabergoline 0.5 MG Oral TabletSCD6Cabergoline Tablets, USP20230412
89ec147b-a6fe-49bb-9af5-52fc2ce5db7fcabergoline 0.5 MG Oral TabletPSN6Cabergoline Tablets, USP20230412
518d43ee-8d33-4abd-96a5-1b6890e59b08cabergoline 0.5 MG Oral TabletSCD5CABERGOLINE TABLETS, USP Rx only20250401
518d43ee-8d33-4abd-96a5-1b6890e59b08cabergoline 0.5 MG Oral TabletPSN5CABERGOLINE TABLETS, USP Rx only20250401
275a6a25-c3c9-4258-a610-0b00752517f7cabergoline 0.5 MG Oral TabletSCD4CABERGOLINE TABLETS Rx only20251208
275a6a25-c3c9-4258-a610-0b00752517f7cabergoline 0.5 MG Oral TabletPSN4CABERGOLINE TABLETS Rx only20251208
e0fb5556-de2c-4822-9960-0700e2907890cabergoline 0.5 MG Oral TabletSCD4Cabergoline Tablets, USP20241114
e0fb5556-de2c-4822-9960-0700e2907890cabergoline 0.5 MG Oral TabletPSN4Cabergoline Tablets, USP20241114
c85d676c-e23e-468d-9de3-79202d9fad3fcabergoline 0.5 MG Oral TabletPSN4Cabergoline Tablets20200118
c85d676c-e23e-468d-9de3-79202d9fad3fcabergoline 0.5 MG Oral TabletSCD4Cabergoline Tablets20200118
bc44d11b-b3f0-4e3d-9da3-4f8852d11734cabergoline 0.5 MG Oral TabletPSN2CABERGOLINE TABLETS, USP Rx only20230727
bc44d11b-b3f0-4e3d-9da3-4f8852d11734cabergoline 0.5 MG Oral TabletSCD2CABERGOLINE TABLETS, USP Rx only20230727
9405c116-4a77-4e14-9ab8-25e899595cdfcabergoline 0.5 MG Oral TabletSCD1Cabergoline Tablets, USP Rx only20250827
9405c116-4a77-4e14-9ab8-25e899595cdfcabergoline 0.5 MG Oral TabletPSN1Cabergoline Tablets, USP Rx only20250827
a246b015-e19c-4b4f-9089-aea1108687bacabergoline 0.5 MG Oral TabletSCD1Cabergoline Tablets, USP Rx only20241003
a246b015-e19c-4b4f-9089-aea1108687bacabergoline 0.5 MG Oral TabletPSN1Cabergoline Tablets, USP Rx only20241003
67db5c74-b0f8-4684-b025-d4c9837c62b6cabergoline 0.5 MG Oral TabletPSN1Cabergoline Tablets, USP Rx only20240708
67db5c74-b0f8-4684-b025-d4c9837c62b6cabergoline 0.5 MG Oral TabletSCD1Cabergoline Tablets, USP Rx only20240708
7699d938-3f62-4e13-9b33-3e581310b9f3cabergoline 0.5 MG Oral TabletPSN1CABERGOLINE TABLETS, USP Rx only20230828
7699d938-3f62-4e13-9b33-3e581310b9f3cabergoline 0.5 MG Oral TabletSCD1CABERGOLINE TABLETS, USP Rx only20230828